Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Chemours Are Soaring Today

By Lou Whiteman – Updated May 5, 2020 at 2:37PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company's former parent expects to settle a dispute over retained environmental liabilities.

What happened

Shares of Chemours (CC 0.67%) traded up 13% on Tuesday after former parent DuPont (DD 0.08%) said it is likely to renegotiate the companies' separation agreement. Chemours has sued DuPont over the environmental liabilities it retained in the original agreement, but the company's initial court efforts have not been promising.

So what

Chemours, a major supplier of titanium dioxide, was spun out of DuPont in 2015 and held on to a lot of legacy environmental liabilities as part of the separation agreement. Chemours has argued that DuPont's estimates of how much its former subsidiary would be on the hook for were off base and were not prepared in good faith.

A pile of white pigment.

Image source: Getty Images.

Chemours had gone to court to try to get DuPont to foot more of the bill, but the company on March 31 was dealt a setback when the litigation was dismissed on technical grounds. Sam Glasscock 3d of the Delaware Court of Chancery granted DuPont's dismissal request, ruling that he had no jurisdiction to hear the case because the separation agreement between the companies states that all disputes arising from the spinoff are subject to binding arbitration. Chemours has appealed that ruling.

DuPont CEO Edward Breen, during his company's post-earnings call, said he was pleased with the push to go to arbitration "because it's a quicker process than going through the court system." He also predicted the two sides would be able to come to an agreement.

"My opinion is, there probably will be a settlement with Chemours that will occur here at some point in time, where we will renegotiate the agreement we have between the companies," Breen said.

Now what

Chemours shares crashed after the late March court decision because what investors fear most is the company having to go it alone in cases involving PFOA, a chemical once used in nonstick coatings and other products.

There is still a lot of risk with these suits, but it appears from Breen's comments that Chemours' former parent is not just trying to walk away from the claims. That's reason enough to send the shares flying heading into Chemours' earnings report Tuesday evening.

Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Chemours Company Stock Quote
The Chemours Company
$24.10 (0.67%) $0.16
DuPont de Nemours, Inc. Stock Quote
DuPont de Nemours, Inc.
$50.09 (0.08%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.